Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 107

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 107
---
 driving the development of our assets).                                   
 ──────────────────────────────────────────────────────────────────────────────────────────────────────

Agreement
with Kilin wata

In February 2021, Radiopharm
entered into an agreement with Kilinwata Investments Pty Ltd (“ Kilinwata”), an entity controlled by Paul Hopper, as trustee
for the Life Science Portfolio Managers Trust. Under the agreement, Kilinwata agreed to ensure that Paul Hopper provides services as Executive
Chairman of the Company. The Company has agreed to pay Kilinwata a fee of A$20,833 per month which is reviewed annually, plus a 33% bonus
according to agreed performance targets. The Company has the right to terminate Mr. Hopper’s appointment by providing a 12-month
notice to Kilinwata. Mr. Hopper is also entitled to options with details to be agreed and subject to shareholder approval.

Agreement with Acclime

In February 2021, we entered
into an engagement letter with CFO Solution HQ Pty Ltd, which was acquired by Acclime Corporate Services Australia Pty Ltd in 2023 (“ Acclime”).
In May 2025, we entered into a new retainer agreement with Acclime. Under the terms of the agreement, Acclime has agreed to provide 283
days per annum of company secretarial services, CFO and statutory reporting, accounting and financial management, book-keeping services
and payroll processing. We have agreed to pay A$31,833.33 per month for such services and we agreed to pay fees on a time-spent basis
for other services that Acclime is asked to provide. The agreement may be terminated by either party for cause by providing a 3-month
written notice to the other party.

Other key
personnel have individual service agreements as follows:

  Riccardo Canevari         Chief Executive Officer and Managing Director                                                                                                                                                         
  Agreement commenced:      September 13, 2021                                                                                                                                                                                    
  Details                   The employment agreement has no fixed term. Each party can terminate                                                                                                                                  
  Base salary               US$555,000 per year.                                                                                                                                                                                  
  Bonus                     50% of base salary.                                                                                                                                                                                   
  Forfeiture Payments       The company has agreed to pay Mr. Riccardo Canevari a total of €399,999 in cash and €399,999 in shares for forfeiture of long-term incentives with his former employment. The expense is cumul